{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:00:41Z","timestamp":1793412041836,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.plefa.2026.102758","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:06:26Z","timestamp":1781136386000},"page":"102758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Specialized pro-resolving mediator (SPM)-enriched supplementation modulates inflammatory biomarkers in patients with symptomatic knee osteoarthritis: Blood plasma analysis from the GAUDI study"],"prefix":"10.1016","volume":"210","author":[{"given":"Ingrid","family":"M\u00f6ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Rodas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"Villal\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Rodas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7883-5900","authenticated-orcid":false,"given":"Josep","family":"Verg\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2026.102758_bib0001","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the global burden of disease study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.plefa.2026.102758_bib0002","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","article-title":"The epidemiology and impact of pain in osteoarthritis","volume":"21","author":"Neogi","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.plefa.2026.102758_bib0003","first-page":"90","article-title":"Osteoarthritis pain, best practice & research","volume":"29","author":"Perrot","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.plefa.2026.102758_bib0004","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12891-019-2895-3","article-title":"Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review","volume":"20","author":"Vitaloni","year":"2019","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.plefa.2026.102758_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1186\/s12891-020-03741-0","article-title":"A patients' view of OA: the global osteoarthritis patient perception survey (GOAPPS), a pilot study","volume":"21","author":"Vitaloni","year":"2020","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.plefa.2026.102758_bib0006","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","article-title":"Synovial inflammation in osteoarthritis progression","volume":"18","author":"Sanchez-Lopez","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.plefa.2026.102758_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/biology9080194","article-title":"Pathogenesis of osteoarthritis: risk factors, regulatory pathways in chondrocytes, and experimental models","volume":"9","author":"He","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.plefa.2026.102758_bib0008","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.plefa.2026.102758_bib0009","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11914-015-0275-y","article-title":"Mechanisms and mediators that drive arthritis pain","volume":"13","author":"Krustev","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.plefa.2026.102758_bib0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2026.102758_bib0011","article-title":"Adaptive mechanisms driving maladaptive pain: how chronic ongoing activity in primary nociceptors can enhance evolutionary fitness after severe injury","volume":"374","author":"Walters","year":"2019","journal-title":"Philos. Trans. R. Soc. L. B Biol. Sci."},{"key":"10.1016\/j.plefa.2026.102758_bib0012","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41366-024-01482-x","article-title":"Adiposity associates with lower plasma resolvin E1 (Rve1): a population study","volume":"48","author":"Barden","year":"2024","journal-title":"Int. J. Obes. (L.)"},{"key":"10.1016\/j.plefa.2026.102758_bib0013","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of inflammation: what controls its onset?","volume":"7","author":"Sugimoto","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.plefa.2026.102758_bib0014","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbalip.2014.08.006","article-title":"Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome","volume":"1851","author":"Serhan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plefa.2026.102758_bib0015","first-page":"24","article-title":"Pharmacokinetics and changes in lipid mediator profiling after consumption of specialized pro-resolving lipid-mediator-enriched marine oil in healthy subjects","author":"Ir\u00fan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plefa.2026.102758_bib0016","article-title":"Proresolving lipid mediators in the respiratory system","author":"Serhan","year":"2024","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.plefa.2026.102758_bib0017","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mam.2017.02.002","article-title":"Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses","volume":"58","author":"Wang","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.plefa.2026.102758_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.03.001","article-title":"Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology","volume":"58","author":"Serhan","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.plefa.2026.102758_bib0019","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plefa.2026.102758_bib0020","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4049\/jimmunol.1601650","article-title":"Novel resolvin D2 receptor axis in infectious inflammation","volume":"198","author":"Chiang","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.plefa.2026.102758_bib0021","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1172\/JCI129448","article-title":"Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions","volume":"129","author":"Chiang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2026.102758_bib0022","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85922","article-title":"Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis","volume":"1","author":"Norling","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.plefa.2026.102758_bib0023","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-pharmtox-051921-084047","article-title":"Specialized pro-resolving mediators as resolution pharmacology for the control of pain and itch","volume":"63","author":"Ji","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.plefa.2026.102758_bib0024","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","article-title":"Resolvin D1 binds human phagocytes with evidence for proresolving receptors","volume":"107","author":"Krishnamoorthy","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.plefa.2026.102758_bib0025","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbalip.2012.07.011","article-title":"Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS\/MS","volume":"1821","author":"Giera","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plefa.2026.102758_bib0026","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1373\/clinchem.2012.190199","article-title":"Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation","volume":"58","author":"Mas","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.plefa.2026.102758_bib0027","doi-asserted-by":"crossref","first-page":"C39","DOI":"10.1152\/ajpcell.00024.2014","article-title":"Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue","volume":"307","author":"Colas","year":"2014","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.plefa.2026.102758_bib0028","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00216-014-8412-5","article-title":"Determination of omega-6 and omega-3 PUFA metabolites in human urine samples using UPLC\/MS\/MS","volume":"407","author":"Sasaki","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.plefa.2026.102758_bib0029","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/mi.2015.99","article-title":"Human milk proresolving mediators stimulate resolution of acute inflammation","volume":"9","author":"Arnardottir","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.plefa.2026.102758_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/REP-14-0549","article-title":"Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors","volume":"149","author":"Keelan","year":"2015","journal-title":"Reproduction"},{"key":"10.1016\/j.plefa.2026.102758_bib0031","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4895","article-title":"Resolution metabolomes activated by hypoxic environment","volume":"5","author":"Norris","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.plefa.2026.102758_bib0032","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.4049\/jimmunol.1201272","article-title":"Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat","volume":"189","author":"Claria","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.plefa.2026.102758_bib0033","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.1800806","article-title":"Cutting edge: human vagus produces specialized proresolving mediators of inflammation with electrical stimulation reducing proinflammatory eicosanoids","volume":"201","author":"Serhan","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.plefa.2026.102758_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055859","article-title":"Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial","volume":"8","author":"Pruss","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.plefa.2026.102758_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2013.12.024","article-title":"Resolution of inflammation is altered in Alzheimer's disease","volume":"11","author":"Wang","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.plefa.2026.102758_bib0036","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","article-title":"Pro-resolving lipid mediators improve neuronal survival and increase Abeta42 phagocytosis","volume":"53","author":"Zhu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.plefa.2026.102758_bib0037","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S0007114515002093","article-title":"Low-grade inflammation, diet composition and health: current research evidence and its translation","volume":"114","author":"Minihane","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.plefa.2026.102758_bib0038","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2026.102758_bib0039","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13679-014-0124-9","article-title":"Low-grade inflammation, obesity, and diabetes","volume":"3","author":"Pereira","year":"2014","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.plefa.2026.102758_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.907750","article-title":"Obesity, inflammation, and immune system in osteoarthritis","volume":"13","author":"Nedunchezhiyan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.plefa.2026.102758_bib0041","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2020.10.e21","article-title":"Activation of inflammation and resolution pathways of lipid mediators in synovial fluid from patients with severe rheumatoid arthritis compared with severe osteoarthritis","volume":"10","author":"Sano","year":"2020","journal-title":"Asia Pac. Allergy"},{"key":"10.1016\/j.plefa.2026.102758_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.joca.2012.02.393","article-title":"Pro-resolving lipid mediators are present in the joints of osteoarthritis patients","volume":"20","author":"Giera","year":"2012","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.plefa.2026.102758_bib0043","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12967-023-04283-4","article-title":"Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study","volume":"21","author":"M\u00f6ller","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.plefa.2026.102758_bib0044","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.joca.2017.01.018","article-title":"Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans","volume":"25","author":"J\u00f3nasd\u00f3ttir","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.plefa.2026.102758_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75353-6","article-title":"The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery","volume":"10","author":"Schulte","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.plefa.2026.102758_bib0046","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1042\/CS20190067","article-title":"Specialized pro-resolving mediators in diabetes: novel therapeutic strategies","volume":"133","author":"Brennan","year":"2019","journal-title":"Clin. Sci. (L.)"},{"key":"10.1016\/j.plefa.2026.102758_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113965","article-title":"Therapeutic potential of pro-resolving mediators in diabetic kidney disease","volume":"178","author":"Vartak","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.plefa.2026.102758_bib0048","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mam.2017.02.003","article-title":"Specialized pro-resolving mediators in cardiovascular diseases","volume":"58","author":"Fredman","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.plefa.2026.102758_bib0049","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-019-0182-5","article-title":"Resolving atherosclerosis and Alzheimer disease","volume":"16","author":"Fredman","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.plefa.2026.102758_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.702785","article-title":"Specialized pro-resolving mediators mitigate cancer-related inflammation: role of tumor-associated macrophages and therapeutic opportunities","volume":"12","author":"Lavy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.plefa.2026.102758_bib0051","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mam.2017.04.003","article-title":"Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation","volume":"58","author":"Duvall","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.plefa.2026.102758_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5493\/wjem.v12.i1.1","article-title":"New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease","volume":"12","author":"Pascoal","year":"2022","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.plefa.2026.102758_bib0053","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/CIRCRESAHA.119.315506","article-title":"Enriched marine oil supplements increase peripheral blood specialized pro-resolving mediators concentrations and reprogram host immune responses: a randomized double-blind placebo-controlled study","volume":"126","author":"Souza","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.plefa.2026.102758_bib0054","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016113","article-title":"Treatment with a marine oil supplement alters lipid mediators and leukocyte phenotype in healthy patients and those with peripheral artery disease","volume":"9","author":"Schaller","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.plefa.2026.102758_bib0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12967-020-02569-5","article-title":"Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain","volume":"18","author":"Callan","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.plefa.2026.102758_bib0056","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/jn\/nxac075","article-title":"Enriched marine oil supplement increases specific plasma specialized pro-resolving mediators in adults with obesity","volume":"152","author":"Al-Shaer","year":"2022","journal-title":"J. Nutr."},{"key":"10.1016\/j.plefa.2026.102758_bib0057","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.plefa.2026.102758_bib0058","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.plefa.2026.102758_bib0059","first-page":"22","article-title":"Cytokines and chemokines involved in osteoarthritis pathogenesis","author":"Molnar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plefa.2026.102758_bib0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/biologics5030027","article-title":"Advancing early detection of osteoarthritis through biomarker profiling and predictive modelling: a review","volume":"5","author":"Coleman","year":"2025","journal-title":"Biologics"},{"key":"10.1016\/j.plefa.2026.102758_bib0061","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1021\/jasms.4c00211","article-title":"Development and validation of methodologies for the identification of specialized pro-resolving lipid mediators and classic eicosanoids in biological matrices","volume":"35","author":"Dooley","year":"2024","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.plefa.2026.102758_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256226","article-title":"Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients","volume":"16","author":"Palmas","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.plefa.2026.102758_bib0063","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.plefa.2026.102758_bib0064","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.plefa.2026.102758_bib0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/OARRR.S291388","article-title":"Pain: a review of interleukin-6 and its roles in the pain of rheumatoid arthritis","volume":"13","author":"Sebba","year":"2021","journal-title":"Open Access Rheumatol."},{"key":"10.1016\/j.plefa.2026.102758_bib0066","article-title":"Serum levels of proinflammatory cytokines in painful knee osteoarthritis and sensitization","volume":"2015","author":"Imamura","year":"2015","journal-title":"Int. J. Inflam."},{"key":"10.1016\/j.plefa.2026.102758_bib0067","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091343","article-title":"Synovial cytokines significantly correlate with osteoarthritis-related knee pain and disability: inflammatory mediators of potential clinical relevance","volume":"8","author":"Nees","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.plefa.2026.102758_bib0068","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1038\/s41598-021-84582-2","article-title":"Synovial fluid but not plasma interleukin-8 is associated with clinical severity and inflammatory markers in knee osteoarthritis women with joint effusion","volume":"11","author":"Garc\u00eda-Manrique","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.plefa.2026.102758_bib0069","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.phymed.2013.03.021","article-title":"Double-blind placebo-controlled trial of hydroxytyrosol of Olea europaea on pain in gonarthrosis","volume":"20","author":"Takeda","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.plefa.2026.102758_bib0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.nutres.2007.06.003","article-title":"Olive extract supplement decreases pain and improves daily activities in adults with osteoarthritis and decreases plasma homocysteine in those with rheumatoid arthritis","volume":"27","author":"Catherine","year":"2007","journal-title":"Nutr. Res."},{"key":"10.1016\/j.plefa.2026.102758_bib0071","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101060","article-title":"Therapeutic effects of olive and its derivatives on osteoarthritis: from bench to bedside","volume":"9","author":"Chin","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.plefa.2026.102758_bib0072","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrrheum.2012.224","article-title":"Tackling obesity in knee osteoarthritis","volume":"9","author":"Wluka","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.plefa.2026.102758_bib0073","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2337\/db12-0828","article-title":"Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation","volume":"62","author":"Neuhofer","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2026.102758_bib0074","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1096\/fj.201802587R","article-title":"Leukocytes from obese individuals exhibit an impaired SPM signature","volume":"33","author":"L\u00f3pez-Vicario","year":"2019","journal-title":"Faseb J."},{"key":"10.1016\/j.plefa.2026.102758_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41574-024-01047-y","article-title":"Inflammation and resolution in obesity","volume":"21","author":"Sot\u00e1k","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.plefa.2026.102758_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11061213","article-title":"Resolution of inflammation after skeletal muscle ischemia-reperfusion injury: a focus on the lipid mediators lipoxins, resolvins, protectins and maresins","volume":"11","author":"Barnig","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.plefa.2026.102758_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101637","article-title":"Exercise-induced specialized proresolving mediators stimulate AMPK phosphorylation to promote mitochondrial respiration in macrophages","volume":"66","author":"Calderin","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.plefa.2026.102758_bib0078","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2026.102758_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155211","article-title":"Effects of statins on specialized pro-resolving mediators: an additional pathway leading to resolution of inflammation","volume":"132","author":"Radbakhsh","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.plefa.2026.102758_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2021.102334","article-title":"The effects of perioperative dexamethasone on eicosanoids and mediators of inflammation resolution: a sub-study of the PADDAG trial","volume":"173","author":"Barden","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.plefa.2026.102758_bib0081","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.aca.2019.03.020","article-title":"Validated comprehensive metabolomics and lipidomics analysis of colon tissue and cell lines","volume":"1066","author":"Rombouts","year":"2019","journal-title":"Anal. Chim. Acta"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:18:46Z","timestamp":1789039126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327826000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":81,"alternative-id":["S0952327826000360"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102758","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specialized pro-resolving mediator (SPM)-enriched supplementation modulates inflammatory biomarkers in patients with symptomatic knee osteoarthritis: Blood plasma analysis from the GAUDI study","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102758"}}